Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Athletes With Patellar Tendinopathy

NCT07466407 is registered in ClinicalTrials.gov with Universidad Complutense de Madrid as lead sponsor.

NCT NCT07466407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07466407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Athletes With Patellar Tendinopathy
Lead sponsor
Universidad Complutense de Madrid
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
July 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patellar tendinopathy